Infection of myeloid dendritic cells with Listeria monocytogenes leads to the suppression of T cell function by multiple inhibitory mechanisms

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4976-4988

  Popov, Alexey ^a   Driesen, Julia ^a   Abdullah, Zeinab ^b   Wickenhauser, Claudia ^b   Beyer, Marc ^a   Debey Pascher, Svenja ^a   Saric, Tomo ^b   Kummer, Silke ^b   Takikawa, Osamu ^c   Domann, Eugen ^d   Chakraborty, Trinad ^d   Krönke, Martin ^b   Utermöhlen, Olaf ^b   Schultze, Joachim L ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; PROSTAGLANDIN RECEPTOR; TOLL LIKE RECEPTOR 2; TRYPTOPHAN; TUMOR NECROSIS FACTOR; GROWTH INHIBITOR; IMMUNOLOGICAL ADJUVANT; IMMUNOSUPPRESSIVE AGENT; INDOLEAMINE 2,3 DIOXYGENASE;

ARTICLE; BACTERICIDAL ACTIVITY; BLOOD SAMPLING; BONE MARROW CELL; CATABOLISM; CELL FUNCTION; DENDRITIC CELL; FLOW CYTOMETRY; GRANULOMA; GRANULOMATOSIS; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFECTION RESISTANCE; LISTERIOSIS; LYMPH NODE BIOPSY; MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; COCULTURE; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; ENZYME INDUCTION; ENZYMOLOGY; IMMUNOLOGY; IMMUNOPHENOTYPING; LISTERIA MONOCYTOGENES; METABOLISM; MICROBIOLOGY; MONOCYTE; PHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DOWN-REGULATION; ENZYME INDUCTION; GRANULOMA; GROWTH INHIBITORS; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MACROPHAGES; MONOCYTES; MYELOID CELLS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 58149292271     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4976     Document Type: Article

References (59)

1. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823.
2. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19: 93-129.
3. Grivennikov, S. I., A. V. Tumanov, D. J. Liepinsh, A. A. Kruglov, B. I. Marakusha, A. N. Shakhov, T. Murakami, L. N. Drutskaya, I. Forster, B. E. Clausen, et al. 2005. Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: protective and deleterious effects. Immunity 22: 93-104.
4. Tsai, M. C., S. Chakravarty, G. Zhu, J. Xu, K. Tanaka, C. Koch, J. Tufariello, J. Flynn, and J. Chan. 2006. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol. 8: 218-232.
5. Serbina, N. V., T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70.
6. + T lymphocyte responses. J. Immunol. 172: 3725-3735.
7. Kolb-Maurer, A., I. Gentschev, H. W. Fries, F. Fiedler, E. B. Brocker, E. Kampgen, and W. Goebel. 2000. Listeria monocytogenes-infected human dendritic cells: uptake and host cell response. Infect. Immun. 68: 3680-3688. (Pubitemid 30340474)
8. Paschen, A., K. E. Dittmar, R. Grenningloh, M. Rohde, D. Schadendorf, E. Domann, T. Chakraborty, and S. Weiss. 2000. Human dendritic cells infected by Listeria monocytogenes: induction of maturation, requirements for phagolysosomal escape and antigen presentation capacity. Eur. J. Immunol. 30: 3447-3456. (Pubitemid 32005216)
9. de Graaff, P. M., E. C. de Jong, T. M. van Capel, M. E. van Dijk, P. J. Roholl, J. Boes, W. Luytjes, J. L. Kimpen, and G. M. van Bleek. 2005. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J. Immunol. 175: 5904-5911.
10. Popov, A., Z. Abdullah, C. Wickenhauser, T. Saric, J. Driesen, F. G. Hanisch, E. Domann, E. L. Raven, O. Dehus, C. Hermann, et al. 2006. Indoleamine 2,3- dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J. Clin. Invest. 116: 3160-3170. (Pubitemid 44878630)
11. Poncini, C. V., C. D. Alba Soto, E. Batalla, M. E. Solana, and S. M. Gonzalez Cappa. 2008. Trypanosoma cruzi induces regulatory dendritic cells in vitro. Infect. Immun. 76: 2633-2641.
12. Wong, K. A., and A. Rodriguez. 2008. Plasmodium infection and endotoxic shock induce the expansion of regulatory dendritic cells. J. Immunol. 180: 716-726.
13. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
14. Munn, D. H., M. D. Sharma, J. R. Lee, K. G. Jhaver, T. S. Johnson, D. B. Keskin, B. Marshall, P. Chandler, S. J. Antonia, R. Burgess, et al. 2002. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297: 1867-1870.
15. Morelli, A. E., and A. W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7: 610-621. (Pubitemid 47123548)
16. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
17. Popov, A., and J. L. Schultze. 2008. IDO-expressing regulatory dendritic cells in cancer and chronic infection. J. Mol. Med. 86: 145-160. (Pubitemid 351172124)
18. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222.
19. Kalinski, P., C. M. Hilkens, A. Snijders, F. G. Snijdewint, and M. L. Kapsenberg. 1997. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159: 28-35. (Pubitemid 127493681)
20. Selenko-Gebauer, N., O. Majdic, A. Szekeres, G. Hofler, E. Guthann, U. Korthauer, G. Zlabinger, P. Steinberger, W. F. Pickl, H. Stockinger, et al. 2003. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170: 3637-3644. (Pubitemid 36359233)
21. + regulatory T cell proliferation. J. Exp. Med. 202: 919-929.
22. Munn, D. H., and A. L. Mellor. 2007. Indoleamine 2,3-dioxygenase and tumorinduced tolerance. J. Clin. Invest. 117: 1147-1154.
23. Puccetti, P., and U. Grohmann. 2007. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation. Nat. Rev. Immunol. 7: 817-823. (Pubitemid 47480306)
24. Sharma, M. D., B. Baban, P. Chandler, D. Y. Hou, N. Singh, H. Yagita, M. Azuma, B. R. Blazar, A. L. Mellor, and D. H. Munn. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117: 2570-2582.
25. Takikawa, O., T. Kuroiwa, F. Yamazaki, and R. Kido. 1988. Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263: 2041-2048. (Pubitemid 18052167)
26. von Bergwelt-Baildon, M. S., A. Popov, T. Saric, J. Chemnitz, S. Classen, M. S. Stoffel, F. Fiore, U. Roth, M. Beyer, S. Debey, et al. 2006. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 108: 228-237.
27. + T cell activation by inhibition of lck: implications in Hodgkin's lymphoma. Cancer Res. 66: 1114-1122.
28. Zakharova, M., and H. K. Ziegler. 2005. Paradoxical anti-inflammatory actions of TNF-α: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells. J. Immunol. 175: 5024-5033. (Pubitemid 41456385)
29. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8: 89-95. (Pubitemid 28097826)
30. Groux, H., M. Bigler, J. E. de Vries, and M. G. Roncarolo. 1996. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184: 19-29. (Pubitemid 126800292)
31. high, CD43high human monocyte-derived dendritic cells. Mol. Immunol. 44: 1555-1561.
32. MacKenzie, C. R., K. Heseler, A. Muller, and W. Daubener. 2007. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr. Drug Metab. 8: 237-244.
33. Napolitani, G., A. Rinaldi, F. Bertoni, F. Sallusto, and A. Lanzavecchia. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6: 769-776. (Pubitemid 43090462)
34. Chaussabel, D., R. T. Semnani, M. A. McDowell, D. Sacks, A. Sher, and T. B. Nutman. 2003. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 102: 672-681. (Pubitemid 36841991)
35. Cosma, C. L., D. R. Sherman, and L. Ramakrishnan. 2003. The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 57: 641-676.
36. Uehira, K., R. Amakawa, T. Ito, K. Tajima, S. Naitoh, Y. Ozaki, T. Shimizu, K. Yamaguchi, Y. Uemura, H. Kitajima, et al. 2002. Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis. Clin. Immunol. 105: 296-303. (Pubitemid 36016057)
37. Vermi, W., F. Facchetti, E. Riboldi, H. Heine, S. Scutera, S. Stornello, D. Ravarino, P. Cappello, M. Giovarelli, R. Badolato, et al. 2006. Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma. Blood 107: 454-462. (Pubitemid 43076364)
38. Hertz, C. J., S. M. Kiertscher, P. J. Godowski, D. A. Bouis, M. V. Norgard, M. D. Roth, and R. L. Modlin. 2001. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J. Immunol. 166: 2444-2450.
39. Biswas, P. S., V. Pedicord, A. Ploss, E. Menet, I. Leiner, and E. G. Pamer. 2007. Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. J. Immunol. 179: 4520-4528.
40. Petit, J. C., G. Richard, B. Burghoffer, and G. L. Daguet. 1985. Suppression of cellular immunity to Listeria monocytogenes by activated macrophages: mediation by prostaglandins. Infect. Immun. 49: 383-388.
41. + Tr cells. Blood 105: 1162-1169.
42. + T regulatory cell activities in lung cancer. Cancer Res. 65: 5211-5220.
43. Toossi, Z., J. R. Sedor, J. P. Lapurga, R. J. Ondash, and J. J. Ellner. 1990. Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J. Clin. Invest. 85: 1777-1784. (Pubitemid 20192949)
44. Barral-Netto, M., A. Barral, S. B. Santos, E. M. Carvalho, R. Badaro, H. Rocha, S. G. Reed, and W. D. Johnson, Jr. 1991. Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J. Immunol. 147: 281-284.
45. Makis, A. C., E. Galanakis, E. C. Hatzimichael, Z. L. Papadopoulou, A. Siamopoulou, and K. L. Bourantas. 2005. Serum levels of soluble interleukin- 2 receptor alpha (sIL-2Rα) as a predictor of outcome in brucellosis. J. Infect. 51: 206-210.
46. Sheibani, K., C. D. Winberg, S. van de Velde, D. W. Blayney, and H. Rappaport. 1987. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas: an immunohistologic study of 300 cases. Am. J. Pathol. 127: 27-37. (Pubitemid 17062584)
47. Janik, J. E., J. C. Morris, S. Pittaluga, K. McDonald, M. Raffeld, E. S. Jaffe, N. Grant, M. Gutierrez, T. A. Waldmann, and W. H. Wilson. 2004. Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma. Blood 104: 3355-3357.
48. Herbert, K. C., and S. J. Foster. 2001. Starvation survival in Listeria monocytogenes: characterization of the response and the role of known and novel components. Microbiology 147: 2275-2284. (Pubitemid 32785507)
49. Marquis, H., H. G. Bouwer, D. J. Hinrichs, and D. A. Portnoy. 1993. Intracytoplasmic growth and virulence of Listeria monocytogenes auxotrophic mutants. Infect. Immun. 61: 3756-3760. (Pubitemid 23260047)
50. Gutierrez-Preciado, A., R. A. Jensen, C. Yanofsky, and E. Merino. 2005. New insights into regulation of the tryptophan biosynthetic operon in Gram-positive bacteria. Trends Genet. 21: 432-436. (Pubitemid 40981790)
51. Kaufmann, S. H. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11: 129-163.
52. Tufariello, J. M., J. Chan, and J. L. Flynn. 2003. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis. 3: 578-590.
53. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56: 731-740. (Pubitemid 19082507)
54. Ehlers, S., C. Holscher, S. Scheu, C. Tertilt, T. Hehlgans, J. Suwinski, R. Endres, and K. Pfeffer. 2003. The lymphotoxin β receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes. J. Immunol. 170: 5210-5218. (Pubitemid 36554754)
55. Kuuliala, A., R. Nissinen, H. Kautiainen, H. Repo, and M. Leirisalo-Repo. 2006. Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab. Ann. Rheum. Dis. 65: 26-29. (Pubitemid 41815635)
56. Wolf, A. M., D. Wolf, H. Rumpold, A. R. Moschen, A. Kaser, P. Obrist, D. Fuchs, G. Brandacher, C. Winkler, K. Geboes, P. Rutgeerts, and H. Tilg. 2004. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin. Immunol. 113: 47-55. (Pubitemid 39468267)
57. Detkova, Z., V. Kupcova, M. Prikazska, L. Turecky, S. Weissova, and E. Jahnova. 2003. Different patterns of serum interleukin 10 response to treatment with anti-tumor necrosis factor α antibody (infliximab) in Crohn's disease. Physiol. Res. 52: 95-100. (Pubitemid 36356266)
58. Keane, J., S. Gershon, R. P. Wise, E. Mirabile-Levens, J. Kasznica, W. D. Schwieterman, J. N. Siegel, and M. M. Braun. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N. Engl. J. Med. 345: 1098-1104. (Pubitemid 34940777)
59. Slifman, N. R., S. K. Gershon, J. H. Lee, E. T. Edwards, and M. M. Braun. 2003. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α-neutralizing agents. Arthritis Rheum. 48: 319-324.